GET THE FULL COMPANY
ANALYSIS BUNDLE FOR
Agilent Technologies
Who Owns Agilent Technologies?
Understanding Agilent Technologies' ownership is key to its strategic direction. The company emerged from a 1999 spin-off from Hewlett-Packard, marking a significant IPO in Silicon Valley.
Agilent, founded in 1999, is a global leader in life sciences, diagnostics, and applied chemical markets. Its offerings are vital for pharmaceutical research and environmental analysis.
Agilent Technologies, Inc. was established in May 1999, evolving from its roots within Hewlett-Packard, which was founded in 1939. Headquartered in Santa Clara, California, Agilent provides application-focused solutions for the life sciences, diagnostics, and applied chemical markets globally. The company offers a wide range of instruments, software, services, and consumables crucial for pharmaceutical research, drug development, food safety, and environmental analysis. With approximately 18,000 employees worldwide and revenue of $6.51 billion in fiscal year 2024, Agilent holds a significant market position as a global leader in analytical and clinical laboratory technologies. This includes products like those analyzed in the Agilent Technologies BCG Matrix.
Who Founded Agilent Technologies?
Agilent Technologies' origins are tied to the legacy of Hewlett-Packard, founded by William Hewlett and David Packard in 1939. Agilent itself was established in May 1999 as a strategic spin-off of specific business units from Hewlett-Packard. This move was intended to create a more focused entity capable of navigating a competitive market landscape.
Agilent Technologies was not founded by individuals but emerged from a strategic spin-off of Hewlett-Packard's measurement and healthcare businesses. This occurred in May 1999.
The company's initial public offering took place on November 18, 1999, with shares priced at $30. This event was the largest IPO in Silicon Valley's history at that time.
Initially, Hewlett-Packard retained an 85% stake in Agilent. By June 2, 2000, HP had distributed all its Agilent shares to its own shareholders, making Agilent fully independent.
At its launch, Agilent reported approximately $8 billion in annual revenue. The company also had a workforce of around 43,000 employees.
The spin-off allowed Agilent to leverage HP's 60-year legacy in measurement solutions. It enabled a focused approach on its diverse portfolio of products and services.
There is no specific public information detailing equity splits for individual founders of the spun-off entity. Ownership originated from HP's existing shareholder base at the time of the spin-off.
The strategic decision to spin off Agilent Technologies from Hewlett-Packard was a significant corporate restructuring. This move aimed to unlock value and allow both entities to pursue their respective growth strategies more effectively. The spin-off allowed Agilent to build upon the established expertise and market presence inherited from Hewlett-Packard, particularly in areas like electronic measurement and medical diagnostics. Understanding the Revenue Streams & Business Model of Agilent Technologies provides further context on how the company has evolved since its inception.
Complete Agilent Technologies Strategy Bundle
- 6 Full Frameworks, 1 Company – All Pre-Researched
- Each Framework Fully Sourced with Real Company Data
- Built for Strategy Courses, Case Studies & MBA Programs
- Adapt to Your Assignment – No Starting from Scratch
- 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's
How Has Agilent Technologies’s Ownership Changed Over Time?
Agilent Technologies' ownership journey began with its initial public offering in November 1999. Hewlett-Packard initially held a significant stake, but this was fully distributed to HP shareholders by June 2000, marking Agilent's transition to a fully independent public entity.
| Event | Date | Impact on Ownership |
|---|---|---|
| Initial Public Offering (IPO) | November 18, 1999 | Established Agilent as a public company. |
| Distribution of HP Stake | June 2, 2000 | Agilent became fully independent of Hewlett-Packard. |
| Sale of Lumileds Stake | 2005 | Philips acquired Agilent's 47% stake for $1 billion. |
| Divestiture of Verigy | 2005 | Agilent sold its semiconductor test business. |
| Spin-off of Keysight Technologies | November 1, 2014 | Separated into two distinct public companies to focus on different market segments. |
| Acquisition of Sigsense Tech | July 2024 | Strengthened equipment tracking and management capabilities. |
| Acquisition of BioVectra | July 2024 | Acquired for $925 million, bolstering CDMO business in oligonucleotides and CRISPR therapeutics. |
As a publicly traded company on the NYSE under the ticker symbol 'A', Agilent Technologies' ownership is predominantly held by institutional investors, including mutual funds and index funds. These entities collectively manage substantial portions of the company's stock, a common characteristic for large-cap corporations. While precise ownership percentages fluctuate with market activity and are detailed in quarterly filings, individual insider ownership, typically comprising executive management and board members, represents a smaller segment of the overall shareholder base. The company's corporate structure has been significantly shaped by strategic decisions, such as the spin-off of Keysight Technologies in 2014, which aimed to foster independent growth for both entities by attracting distinct investor profiles.
Understanding Agilent Technologies ownership involves recognizing the dominant role of institutional investors. These large funds significantly influence the company's direction and performance.
- Institutional investors are the primary holders of Agilent Technologies stock.
- Mutual funds and index funds represent a significant portion of Agilent Technologies shareholders.
- Individual insider ownership is typically a smaller percentage of the total stock.
- The company's stock ticker is 'A' on the NYSE.
- Strategic acquisitions and divestitures have continually reshaped Agilent Technologies' corporate structure and ownership landscape.
From PESTLE Factors to Full Strategy Bundle
- PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
- Every Strategic Angle Covered – Nothing Left to Research
- Pre-filled with Company-Specific Research
- No Missing Sections for Your Case Study
- One Download Covers Your Entire Company Analysis
Who Sits on Agilent Technologies’s Board?
The Board of Directors at Agilent Technologies is responsible for the company's strategic direction and governance. As of May 21, 2025, the board includes Pascal Soriot and Judy Gawlik Brown, who bring significant expertise from the pharmaceutical, biotechnology, and healthcare industries. Heidi Kunz retired from the board on the same date, concluding over 20 years of service since the company's inception.
| Director Name | Key Role/Affiliation | Committee Assignments |
|---|---|---|
| Pascal Soriot | CEO of AstraZeneca | N/A |
| Judy Gawlik Brown | Founder and CEO of Downtown Advisory | N/A |
| Padraig McDonnell | President, Director, and Chief Executive Officer | N/A |
| Otis Brawley | N/A | N/A |
| Daniel Podolsky | N/A | N/A |
| Sue Rataj | N/A | N/A |
| Dow Wilson | N/A | N/A |
| Mala Anand | N/A | N/A |
| George Scangos | N/A | N/A |
Agilent Technologies operates under a standard one-share-one-vote system, typical for publicly traded entities on the NYSE. The company's governance framework is detailed in its definitive proxy statements, including those filed on January 31, 2025, and a supplement on February 21, 2025, pertaining to the March 13, 2025, annual meeting. A shareholder proposal from John Chevedden, noted in the January 31, 2025 filing, suggested annual election for all directors. The board's stance on this proposal was not specified. The proxy statement also confirmed the election of two directors for three-year terms. There is no evidence of dual-class shares or other structures that would concentrate voting power disproportionately.
Agilent Technologies' ownership is primarily distributed among its shareholders, with a focus on institutional investors. Understanding this structure is key to grasping the company's corporate governance and decision-making processes.
- Agilent Technologies is a publicly traded company.
- Voting power is generally based on a one-share-one-vote principle.
- Institutional investors often hold significant portions of Agilent Technologies stock ownership.
- Information on Agilent Technologies ownership breakdown can be found in regulatory filings.
- The Target Market of Agilent Technologies is influenced by its broad shareholder base.
Agilent Technologies Business Model + Strategy Bundle
- Ideal for Essays, Case Studies & Slides
- Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
- Company-Specific Content Already Organized
- One Bundle Replaces Days of Independent Research
- Buy the Bundle Once. Use Across All Your Assignments
What Recent Changes Have Shaped Agilent Technologies’s Ownership Landscape?
Over the past 3-5 years, Agilent Technologies has seen significant shifts in its ownership landscape, driven by strategic acquisitions and shareholder-focused programs. These developments reflect a broader industry trend towards consolidation and specialization in high-growth life science sectors.
| Development | Date | Details |
|---|---|---|
| Acquisition of BioVectra | July 2024 | Acquired for $925 million, bolstering CDMO capabilities in oligonucleotides and CRISPR therapeutics. |
| Acquisition of Sigsense Tech | July 2024 | Acquisition of an equipment tracking and management platform. |
| Share Repurchase Program Authorization | January 2023 (updated May 2024) | Initial authorization of up to $2 billion, updated with a $2,000 million repurchase authorization, effective March 1, 2023. |
| CFO Departure | Effective July 31, 2025 | Bob McMahon announced departure; Rodney Gonsalves appointed interim CFO. |
Agilent Technologies' ownership trends are closely tied to its strategic growth initiatives and financial management. The company's proactive approach to acquisitions, such as the July 2024 purchase of BioVectra for $925 million and Sigsense Tech, aims to expand its market reach and capabilities in critical areas like oligonucleotide and CRISPR therapeutic manufacturing. Concurrently, the company's commitment to returning value to shareholders is evident through its share repurchase programs. The January 2023 authorization, updated in May 2024 with a $2,000 million repurchase authorization, signals a strategy to potentially enhance earnings per share by reducing the number of outstanding shares. This active management of its capital structure, alongside leadership transitions like the upcoming departure of CFO Bob McMahon effective July 31, 2025, positions Agilent for its ongoing 'Ignite transformation initiative,' which targets revenue and margin improvements through pricing and digital enhancements.
Agilent's recent acquisitions, including BioVectra and Sigsense Tech in July 2024, underscore a strategy to enhance its position in high-demand life science sectors. These moves are key to expanding its contract development and manufacturing capabilities.
The company's share repurchase programs, notably the $2,000 million authorization updated in May 2024, demonstrate a commitment to increasing shareholder value. This can lead to improved earnings per share and a more concentrated ownership base.
Leadership changes, such as the upcoming CFO transition, occur alongside Agilent's 'Ignite transformation initiative.' This initiative aims to boost revenue and margins through pricing and digital improvements.
With analysts forecasting annual revenue growth of 5.6% and a full-year fiscal 2025 revenue outlook between $6.790 billion and $6.870 billion, Agilent presents an interesting investment profile. The stock's trading at a discount to its consensus price target suggests potential upside. Investors interested in the company's journey might find a Brief History of Agilent Technologies insightful.
From Five Forces to Full Company Analysis
- Includes SWOT, PESTLE, BMC, BCG and 4P's
- Pre-Researched with Company-Specific Data
- Best Value for a Complete Analysis
- Ready to Adapt for Your Case Study
- Ready for Essays and Slidesd
- What is Brief History of Agilent Technologies Company?
- What is Competitive Landscape of Agilent Technologies Company?
- What is Growth Strategy and Future Prospects of Agilent Technologies Company?
- How Does Agilent Technologies Company Work?
- What is Sales and Marketing Strategy of Agilent Technologies Company?
- What are Mission Vision & Core Values of Agilent Technologies Company?
- What is Customer Demographics and Target Market of Agilent Technologies Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.